A review of the evidence of health claims for biotherapeutic agents

Microbial Ecology in Health and Disease

Volumn 12, Issue 2, 2000, Pages 65-76

  McFarland, L V ^a  

^a Service de Pharmacologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PROBIOTIC AGENT;

ARTICLE; CANCER PREVENTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; VOMITING;

EID: 0033789692     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/089106000435446     Document Type: Article

References (123)

1. Development of consumer probiotics for the US Market
2. Colonization resistance
3. How intestinal bacteria cause disease
4. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea
5. Prevention of diarrhea by the probiotic, Lactobacillus GG
6. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children
7. Occurrence of diarrhea in children receiving oral antibiotics with or without probiotic supplementation with Lactobacillus GG
8. Biotherapy for antibiotic-associated and other diarrhoeas
9. Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects
10. Efficacy of SF68 in the treatment of acute diarrhea. A placebo-controlled trial
11. Biotherapeutic agents for Clostridium difficile-associated disease
12. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics
13. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections
14. Microecologic approaches for traveler's diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea
15. Functional food science and gastrointestinal physiology and function
16. The effect of probiotics on Clostridium difficile diarrhea
17. Controlled double-blind clinical trials of Ultra-Levure: Multicentre study by 25 physicians in 388 cases
18. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
19. Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared to placebo
20. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
21. Comment on 'the lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in elderly patients'
22. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
23. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
24. A new combination treatment for recurrent Clostridium difficile infections: Saccharomyces boulardii and high dose vancomycin
25. Prophylaxe der reisediarrhoe mit Saccharomyces boulardii
26. Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: A prospective randomized trial
27. Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation
28. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea
29. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children
30. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial
31. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
32. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea
33. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
34. A prospective randomized placebo-controlled trial of Lactobacillus GG in combination with standard antibiotics for the treatment of Clostridium difficile infection
35. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea
36. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients
37. Probiotic spectra of lactic acid bacteria (LAB)
38. Prevention of colon cancer by pre- and probiotics: Evidence from laboratory studies
39. Intestinal floras of populations that have a high risk of colon cancer
40. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens
41. Effect of consumption of lactic cultures on human health
42. Antimutagenic properties of probiotic bacteria and of organic acids
43. The intestinal microflora and the colon cancer connection
44. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites
45. Intestinal microflora: Metabolism of drugs and carcinogens
46. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats
47. Lactobacilli and azoreductase activity in the murine cecum
48. The effect of oral administration on Lactobacillus and antibiotics on intestinal bacterial activity and chemical induction of large bowel tumors
49. Contrasting effects of butyrate on the expression of phenotypic markers of differentation in neoplastic and non-neoplastic colonic epithelial cells in vitro
50. Antitumor activity of Lactobacillus casei in mice
51. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice
52. Antitumor effect of Bifidobacterium infantis in mice
53. Effect of feeding fermented milk on the incidence of chemically induced colon tumors in rats
54. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine in dihydrochloride-induced intestinal cancer in rats
55. Dietary fat and the risk of breast cancer
56. Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology
57. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study
58. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP study group
59. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP study group
60. Anticholesterolemic property of Lactobacillus acidophilus yogurt fed to mature boars
61. Assimilation of cholesterol by Lactobacillus acidophilus
62. Serum cholesterol levels in axenic mice colonized with Enterococcus faecium and Lactobacillus acidophilus
63. Effects of skim milk and its fermented product by Lactobacillus acidophilus on plasma and liver lipid levels in diet-induced hypertriglyceridemic rats
64. Serum cholesterol and bowel flora in the newborn
65. Short-term hypolipidemic effects of oral Lactobacillus sporogenes therapy in patients with primary dyslipidemias
66. Lactobacillus effects on cholesterol: In vitro and in vivo results
67. Effects of probiotics and prebiotics on blood lipids
68. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance
69. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children
70. Probiotics: A novel approach in the management of food allergy
71. Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: A placebo effect?
72. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose
73. Strains and species of lactice acid bacteria in fermented milks (yogurts): Effect on in vivo lactose digestion
74. Gut flora in normal and disordered states
75. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii
76. Saccharomyces boulardii stimulates an intestinal IgA immune response to Clostridium difficile toxin A in mice
77. Saccharomyces boulardii stimulates the host phagocytic system and type 1 cytokine production
78. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children
79. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
80. Improved immunogenicity of oral D x RRV reassortment rotavirus vaccine by Lactobacillus casei GG
81. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes
82. Effects of intrajejunal perfusion and chronic ingestion of Lactobacillus johnsonii strain Lal on serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy humans
83. How do you treat refractory pouchitis and when do you decide to remove the pouch?
84. D-Lactic acidosis: A review of clinical presentation, biochemical features, and pathophysiologic mechanisms
85. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia
86. Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production
87. Bifidobacterial supplementation reduces the incidence of necrotizing entercolitis in a neonatal rat model
88. Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administrate of Saccharomyces boulardii
89. Dose effect of oral Saccharomyces boulardii treatments on morbidity and mortality in immunosuppressed mice
90. Expansion of alpha-beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus
91. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: Additive effects of dietary lactulose and calcium
92. Adhesion of clinical Lactobacillus isolates to human intestinal mucosal models
93. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection
94. Vaginal microflora associated with bacterial vaginosis in pregnant Japanese and Thai women
95. The role of naturally occurring and exogenously supplied lactobacilli in the human vagina
96. Biotherapeutic agents as therapy for vaginitis
97. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women
98. Pathogenesis of urinary tract infectionexperimental studies of vaginal resistance to colonization
99. Biotherapeutic agents to prevent cystitis in women
100. Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reaction-based detection system
101. Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR
102. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria
103. Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study
104. Colonization resistance of defined bacterial plaques to Streptococcus mutans implantation on teeth in a model mouth
105. The therapeutic efficacy of probiotics for the correction of microfloral imbalance in periodontitis
106. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome
107. Toxicological aspects on the release and systemic uptake of mercury from dental amalgam
108. Treatment of rheumatoid arthritis with a peptide diet. A randomized, controlled trial
109. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice
110. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet
111. Chronic septic arthritis and osteomyelitis in a prosthetic knee joint due to Clostridium difficile
112. Reactive arthritis to Clostridium difficile in a child
113. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
114. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
115. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
116. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities on the colonic flora in humans
117. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: Decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides
118. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults
119. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans